Trial Profile
A PHASE 1 STUDY TO INVESTIGATE THE ABSORPTION, METABOLISM, AND EXCRETION OF [ISOTHIAZOLYL-3-14C]-LURASIDONE FOLLOWING POSTPRANDIAL SINGLE ORAL DOSE ADMINISTRATION IN HEALTHY MALE SUBJECTS.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Aug 2023
Price :
$35
*
At a glance
- Drugs Lurasidone (Primary)
- Indications Autistic disorder; Bipolar depression; Bipolar disorders; Major depressive disorder; Psychiatric disorders; Schizophrenia
- Focus Pharmacokinetics
- Acronyms RI-AME
- Sponsors Dainippon Sumitomo Pharma
- 11 Mar 2010 New trial record